Trump Administration Weighs Cuts to HIV Prevention Programs, Raising Alarm Among Experts

Proposals include consolidating CDC and HRSA efforts, risking decades of progress in reducing HIV infections domestically and globally.

The Trump administration is considering significant funding cuts to the CDC's HIV prevention program, which has been instrumental in reducing new infections by 18% between 2018 and 2022.
Plans are being discussed to consolidate CDC and HRSA HIV programs under HRSA to reduce costs, though no final decisions have been made.
Global HIV medication supplies are at risk after a USAID funding freeze disrupted PEPFAR, with eight countries potentially running out of medications within months.
Public health experts warn that these cuts could reverse progress toward the 2030 goal of reducing new HIV cases by 90% and disproportionately impact marginalized communities.
CDC funding supported over 22 million HIV tests in 2022, connecting thousands of newly diagnosed individuals to critical healthcare services.